S 5809 New York Senate · 2025 Regular Session

Relates to the regulation of cannabinoid hemp products

This bill repeals emergency regulations restricting hemp-derived cannabinoid products and allows licensed retailers to sell all forms of cannabinoid hemp (including products containing Delta-8, Delta-10, and other THC isomers) starting January 1, 2026. It requires mandatory labeling for all such products, including nutrition facts, an FDA disclaimer, and milligram potency per serving. Smoking products (like flower, cigarettes, or pre-rolls) must be sold only to adults 21+ in licensed cannabis stores. The bill also nullifies any prior rules banning specific cannabinoid hemp sales, while requiring safety rules from the cannabis control board that don’t block sales.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 3, 2025 Last action Jan 7, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
2
Jan 7, 2026
Committee
REFERRED TO INVESTIGATIONS AND GOVERNMENT OPERATIONS
upper
Mar 3, 2025
Committee
REFERRED TO INVESTIGATIONS AND GOVERNMENT OPERATIONS
upper
1 primary · 1 co-sponsor

Sponsors